Humira®, manufactured by AbbVie, is again at the top of the list and semaglutide (Ozempic® and Wegovy ... construction (4.9%), water services (5.1%) and medical gases (4%). Pharmacy projections ...

Novo Nordisk shares surged on the results of a new obesity-drug study Friday. The Danish pharmaceutical giant behind Ozempic ...

and medical gases (4%). Pharmacy projections are based on Vizient client purchases from Oct. 1, 2023, through Sept. 30, 2024. Non-pharmacy supply chain projections are based on a Vizient analysis of ...

Fact checked by Stella Osoba Weight loss drugs are considered an effective way to slim down. While there are health risks, ...

Amid a new year boom in demand the National Pharmacy Association (NPA ... its effect size emerged , compared to the "gorilla" of Wegovy. The two biggest selling GLP-1 drugs are branded as Wegovy ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

In a Phase 2b trial, older patients taking Novo Nordisk’s Wegovy and Veru’s experimental drug, called enobosarm, lost on average 1.2% of lean mass after 16 weeks, compared with a 4.1% loss in ...

A major analysis of more than 1.2 million medical records has found popular diabetes and weight loss drugs, including Ozempic and Wegovy, may also reduce the risk of other health issues.

NOVO.B), which makes Ozempic and Wegovy, is now Europe's largest company by market capitalization, largely due to the popularity of the GLP-1 medications. (Even larger is U.S.-based Eli Lilly & Co ...

Clinics in Columbus, Cleveland, Dayton, and Cincinnati have lost their licenses to distribute dangerous drugs after the Ohio ...